6533b832fe1ef96bd129ad89

RESEARCH PRODUCT

Followup of irradiated prostatic carcinoma by aspiration biopsy.

R. HohenfellnerK.h. KurthJens E. AltweinD. Skoluda

subject

Malemedicine.medical_specialtyUrologyAspiration biopsyCarcinomamedicineHumansIn patientCobalt RadioisotopesDiethylstilbestrolAgedEstradiolbusiness.industryBiopsy NeedleEndocrine therapyProstatic NeoplasmsRadiotherapy aloneMiddle Agedmedicine.diseasePrognosisSurgeryCombined radiotherapyRadiologyRadioisotope TeletherapybusinessFollow-Up Studies

description

AbstractOf 66 patients with irradiated prostatic carcinoma 53 were controlled regularly by repeat aspiration biopsy every 6 months. Local sterilization was achieved in 43 per cent but the results of combined radiotherapy (endocrine therapy plus irradiation) were only 8 per cent more favorable than those in patients treated by radiotherapy alone. Thus, endocrine therapy is not warranted before the radiation effect is evaluated. Post-radiation treatment should be determined by the clinical and bioptic findings.

10.1016/s0022-5347(17)58555-9https://pubmed.ncbi.nlm.nih.gov/870712